Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning

Peer review reports

Original Submission
21 Mar 2024	Submitted	Original manuscript
30 Apr 2024	Reviewed	Reviewer Report
21 Jun 2024	Reviewed	Reviewer Report
13 Aug 2024	Author responded	Author comments - Jun Ishigooka
Resubmission - Version 2
13 Aug 2024	Submitted	Manuscript version 2
16 Aug 2024	Author responded	Author comments - Jun Ishigooka
Resubmission - Version 3
16 Aug 2024	Submitted	Manuscript version 3
Publishing
20 Aug 2024	Editorially accepted
5 Sep 2024	Article published	10.1186/s12888-024-06031-4

Back to article page